# Filing Detail

Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0000950170-23-000131
Filing Date
2023-01-04
Accepted
2023-01-04 16:29:19
Documents
8

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 424B5 | proj_geode_no_pfw_pre_pr.htm | 424B5 | 1819967
2 | GRAPHIC | img185144651_0.jpg | GRAPHIC | 4766
3 | GRAPHIC | img185144651_1.jpg | GRAPHIC | 576509
4 | GRAPHIC | img185144651_2.jpg | GRAPHIC | 384053
5 | GRAPHIC | img185144651_3.jpg | GRAPHIC | 545898
6 | GRAPHIC | img185144651_4.jpg | GRAPHIC | 429184
7 | GRAPHIC | img185144651_5.jpg | GRAPHIC | 537906
8 | GRAPHIC | img185144651_6.jpg | GRAPHIC | 3209
| Complete submission text file | 0000950170-23-000131.txt |  | 5237728

Mailing Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404
Business Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

EIN.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-269111 | Film No.: 23506890
SIC: 2834 Pharmaceutical Preparations